Dianabol or turinabol for a first oral?

Dianabol for simplicity of effect and management. Turinabol is more subtle: visible gains are slow (apparent at W3-W4 vs W1 for dianabol), and most beginner users interpret it as 'not very effective' due to lack of fast visual feedback. Dianabol gives immediate feedback (strength and volume) which is psychologically rewarding. The downside: half of dbol gains leave on cessation, while tbol gains are better retained. For a patient and quality-oriented user, turinabol. For others, dianabol remains the entry-level standard.

Why is turinabol detectable 12 months?

Sobolevsky 2012 identified several long-term turinabol metabolites (including 4-chloro-18-nor-17β-hydroxymethyl-17α-methyl-5β-androst-13-en-3α-ol) that accumulate in adipose tissue and are released progressively. The Russian Sochi 2014 scandal stemmed from retroactive re-analysis of stored samples with the new detection method of these long metabolites — hence the disqualification of many athletes years after their competition. For any WADA-tested athlete, turinabol is to be absolutely avoided.

How much realistic gains with turinabol alone?

In solo cycle (inadvisable due to suppression without androgen substitution): 40-60 mg/d × 8 weeks = +3 to +5 kg net lean mass retained at 3 months post-PCT. Excellent retention profile because little water retention. In combination testo 400 mg/week + tbol 40 mg/d × 8 weeks, the additive effect is more marked: +6 to +8 kg of which the majority retained. It is an excellent oral for users wanting to gain without bloat or brutal hormonal transformation.

Which AI to choose with dianabol?

The methylestradiol from dianabol aromatization is partially resistant to anastrozole. Exemestane (Aromasin) 12.5 mg EOD is more effective because it inhibits aromatase irreversibly (suicide enzyme), and its metabolite has slight androgenic activity. If gynecomastia already established, add nolvadex 20 mg/d. Measured estradiol monitoring (not only symptomatic) at W2 and W4 to titrate.

Is turinabol less hepatotoxic than dianabol?

Moderately. Both are 17α-alkylated, the main toxicity factor is this common modification. Niedfeldt 2018 classifies dianabol as more hepatotoxic mainly due to higher recreational doses and the combination of acute + chronic toxicity. Turinabol generates more modest ALT/AST elevations in bodybuilding practice, but the cholestasis risk remains present beyond 8 weeks. No 17α-alkylated oral is 'safe for the liver'.

Can you extend a turinabol cycle beyond 8 weeks?

Theoretically yes (turinabol is better tolerated long-term than dianabol), but practically not recommended. The cholestasis risk and lipid profile degradation become significant beyond 8 weeks for any 17α-alkylated drug. Prefer 6-8 weeks of turinabol then switch to an injectable (primobolan or masteron) to extend the cycle if necessary. No oral should be taken continuously on long cycle.

What PCT after dianabol or turinabol alone?

Start 3-4 days after last intake (short half-life). For dianabol alone: nolvadex 20-40 mg/d × 4-6 weeks, sufficient in most cases. For turinabol alone: nolvadex 20 mg/d × 4 weeks, sometimes sufficient at moderate dose. If T total panel < 300 ng/dL at W4 post-cycle, extend PCT to 6 weeks and add clomid 25 mg/d. No hCG needed in oral solo cycle. Complete panel (T total, LH, FSH, E2) at W6 post-PCT to confirm recovery.

Break between two oral cycles?

Minimum 8 weeks strict hepatic break without any 17α-alkylated drug. Hepatocyte regeneration is rapid (at 2-3 weeks transaminases return to normal in most), but complete resolution of cellular micro-lesions takes longer. Resuming any other oral before 8 weeks accumulates damage. Take advantage of the break to restart the HPG axis via clean PCT and do a complete panel. Resume an oral cycle only after biological panel back to normal.

Dianabol vs Turinabol: complete comparison (orals, wet vs dry gains)

Q: Break between two oral cycles?

Minimum 8 weeks strict hepatic break without any 17α-alkylated drug. Hepatocyte regeneration is rapid (at 2-3 weeks transaminases return to normal in most), but complete resolution of cellular micro-lesions takes longer. Resuming any other oral before 8 weeks accumulates damage. Take advantage of the break to restart the HPG axis via clean PCT and do a complete panel. Resume an oral cycle only after biological panel back to normal.

Critère	dianabol	turinabol
Anabolic/androgenic ratio	90-210:40-60	53-100:6
Half-life	~4-6 h	~16 h
Aromatization	Yes (methylestradiol)	No
Water retention	Marked	Minimal
Strength and volume	Fast (W1-W2)	Progressive (W3-W6)
Typical dose	20-40 mg/d	40-60 mg/d
Hepatotoxicity	High	Moderate
Detection (doping)	~5 wk	~12 months

Quand choisir dianabol

Dianabol (methandrostenolone) is the historical mass oral, created in the 1950s by John Ziegler as American response to the Soviet anabolic program. Choose it for: (1) a classic kickstart of an injectable mass cycle, (2) a cycle oriented toward fast gains and explosive strength, (3) a user looking for the visible muscular 'pop' effect from D7-D10. Hartgens 2004 documents the fast gains/time curve thanks to marked aromatization (the methylestradiol metabolite contributes to water retention and visible muscle swelling) and immediate stimulation of muscular protein synthesis. Typical dose 25-30 mg/d × 4-6 weeks as kickstart of a testosterone cycle, split in 2-3 daily intakes (half-life ~5 h). Side effects to anticipate (Kicman 2008, Smit 2022, Niedfeldt 2018): abundant water retention with swelling of face and ankles, dose-dependent hypertension in ~60% of users (Smit 2022: HAARLEM study), systematic but reversible ALT/AST elevation, possible gynecomastia if AI insufficient — the methylestradiol from aromatization is partially resistant to anastrozole, so prefer exemestane 12.5 mg EOD or letrozole 1.25 mg. Inadequate for users seeking clean and durable gains: half of the kilos taken leave on cessation with the drop of water retention.

Quand choisir turinabol

Turinabol (chlorodehydromethyltestosterone, Oral Turinabol) is the 'dry' oral par excellence: no aromatization, no water retention, slow and qualitative gains. Choose it for: (1) a quality cycle (lean bulk or maintenance during cut) where retention is undesirable, (2) a light oral kickstart for intermediate user wanting to avoid dianabol bloat, (3) a 'visual' cycle without brutal hormonal transformation. Pharmacological profile (Saartok 1984, Kicman 2008): low androgenicity (little acne, little hair loss), no aromatization so no AI needed for tbol alone, moderate HPG suppression. Drawbacks to anticipate (Niedfeldt 2018): real hepatotoxicity although less than dianabol (17α methylation effect persists), unfavorable lipid profile (HDL crash), and exceptionally long doping detectability — Sobolevsky 2012 demonstrated that long-term turinabol metabolites remain detectable up to 12 months (origin of the Sochi 2014 scandal and many retroactive requalifications). For any WADA-tested athlete, this is the AAS to absolutely avoid. Typical dose 40-60 mg/d × 6-8 weeks, split in 2 intakes (half-life ~16 h).

Combinaison ?

The dianabol + turinabol combo has no simultaneous interest: two 17α-alkylated orals together double the hepatic load without net additive anabolic benefit (protein synthesis saturates at an androgen receptor occupancy threshold). If you want both effects, structure in sequence on the same cycle: dianabol 25 mg/d × 4 weeks as kickstart (W1-W4) for fast gains and retention, 2-week oral break (W5-W6) for hepatic recovery, then turinabol 40 mg/d × 4 weeks (W7-W10) to maintain gains without stacking estrogenic retention. Always on strong testosterone base (400-500 mg/week). For dianabol, AI from D1 (exemestane 12.5 mg EOD preferred to manage methylestradiol resistant to anastrozole). For turinabol, no AI needed but E2 panel at W8 to verify testo alone does not push aromatization too much. ALT/AST, lipids, BP monitoring at W0, W4, W8, W12 of full cycle. Hepatoprotectors (TUDCA 500 mg, NAC 1200 mg) recommended during oral blocks. Sample 14-week sequential timeline: W0 baseline complete panel + ECG if cardiovascular risk factors, W1 dianabol 25 mg/d + AI from D1, W2 first ALT/AST + BP check, W4 ALT/AST + lipids + measured E2, dianabol stop end of W4, W5-W6 oral-free hepatic recovery (weekly ALT/AST), W7 ALT/AST normalized? then turinabol 40 mg/d start, W9 ALT/AST + lipids, W11 turinabol stop, W14 last testo, W17 PCT start. Doping warning: turinabol 12-month detection window is critical for any tested athlete — even if you stop the cycle 6 months before competition, samples may still test positive due to the long-term metabolites. Sleep consideration: dianabol commonly causes elevated heart rate and disrupted sleep, especially with evening dosing — split doses earlier in the day.

FAQ

Dianabol or turinabol for a first oral?: Dianabol for simplicity of effect and management. Turinabol is more subtle: visible gains are slow (apparent at W3-W4 vs W1 for dianabol), and most beginner users interpret it as 'not very effective' due to lack of fast visual feedback. Dianabol gives immediate feedback (strength and volume) which is psychologically rewarding. The downside: half of dbol gains leave on cessation, while tbol gains are better retained. For a patient and quality-oriented user, turinabol. For others, dianabol remains the entry-level standard.
Why is turinabol detectable 12 months?: Sobolevsky 2012 identified several long-term turinabol metabolites (including 4-chloro-18-nor-17β-hydroxymethyl-17α-methyl-5β-androst-13-en-3α-ol) that accumulate in adipose tissue and are released progressively. The Russian Sochi 2014 scandal stemmed from retroactive re-analysis of stored samples with the new detection method of these long metabolites — hence the disqualification of many athletes years after their competition. For any WADA-tested athlete, turinabol is to be absolutely avoided.
How much realistic gains with turinabol alone?: In solo cycle (inadvisable due to suppression without androgen substitution): 40-60 mg/d × 8 weeks = +3 to +5 kg net lean mass retained at 3 months post-PCT. Excellent retention profile because little water retention. In combination testo 400 mg/week + tbol 40 mg/d × 8 weeks, the additive effect is more marked: +6 to +8 kg of which the majority retained. It is an excellent oral for users wanting to gain without bloat or brutal hormonal transformation.
Which AI to choose with dianabol?: The methylestradiol from dianabol aromatization is partially resistant to anastrozole. Exemestane (Aromasin) 12.5 mg EOD is more effective because it inhibits aromatase irreversibly (suicide enzyme), and its metabolite has slight androgenic activity. If gynecomastia already established, add nolvadex 20 mg/d. Measured estradiol monitoring (not only symptomatic) at W2 and W4 to titrate.
Is turinabol less hepatotoxic than dianabol?: Moderately. Both are 17α-alkylated, the main toxicity factor is this common modification. Niedfeldt 2018 classifies dianabol as more hepatotoxic mainly due to higher recreational doses and the combination of acute + chronic toxicity. Turinabol generates more modest ALT/AST elevations in bodybuilding practice, but the cholestasis risk remains present beyond 8 weeks. No 17α-alkylated oral is 'safe for the liver'.
Can you extend a turinabol cycle beyond 8 weeks?: Theoretically yes (turinabol is better tolerated long-term than dianabol), but practically not recommended. The cholestasis risk and lipid profile degradation become significant beyond 8 weeks for any 17α-alkylated drug. Prefer 6-8 weeks of turinabol then switch to an injectable (primobolan or masteron) to extend the cycle if necessary. No oral should be taken continuously on long cycle.
What PCT after dianabol or turinabol alone?: Start 3-4 days after last intake (short half-life). For dianabol alone: nolvadex 20-40 mg/d × 4-6 weeks, sufficient in most cases. For turinabol alone: nolvadex 20 mg/d × 4 weeks, sometimes sufficient at moderate dose. If T total panel < 300 ng/dL at W4 post-cycle, extend PCT to 6 weeks and add clomid 25 mg/d. No hCG needed in oral solo cycle. Complete panel (T total, LH, FSH, E2) at W6 post-PCT to confirm recovery.
Break between two oral cycles?: Minimum 8 weeks strict hepatic break without any 17α-alkylated drug. Hepatocyte regeneration is rapid (at 2-3 weeks transaminases return to normal in most), but complete resolution of cellular micro-lesions takes longer. Resuming any other oral before 8 weeks accumulates damage. Take advantage of the break to restart the HPG axis via clean PCT and do a complete panel. Resume an oral cycle only after biological panel back to normal.

Dianabol vs Turinabol: complete comparison (orals, wet vs dry gains)

Critère	dianabol	turinabol
Anabolic/androgenic ratio	90-210:40-60	53-100:6
Half-life	~4-6 h	~16 h
Aromatization	Yes (methylestradiol)	No
Water retention	Marked	Minimal
Strength and volume	Fast (W1-W2)	Progressive (W3-W6)
Typical dose	20-40 mg/d	40-60 mg/d
Hepatotoxicity	High	Moderate
Detection (doping)	~5 wk	~12 months

Quand choisir dianabol

Quand choisir turinabol

Combinaison ?

FAQ

Dianabol or turinabol for a first oral?: Dianabol for simplicity of effect and management. Turinabol is more subtle: visible gains are slow (apparent at W3-W4 vs W1 for dianabol), and most beginner users interpret it as 'not very effective' due to lack of fast visual feedback. Dianabol gives immediate feedback (strength and volume) which is psychologically rewarding. The downside: half of dbol gains leave on cessation, while tbol gains are better retained. For a patient and quality-oriented user, turinabol. For others, dianabol remains the entry-level standard.
Why is turinabol detectable 12 months?: Sobolevsky 2012 identified several long-term turinabol metabolites (including 4-chloro-18-nor-17β-hydroxymethyl-17α-methyl-5β-androst-13-en-3α-ol) that accumulate in adipose tissue and are released progressively. The Russian Sochi 2014 scandal stemmed from retroactive re-analysis of stored samples with the new detection method of these long metabolites — hence the disqualification of many athletes years after their competition. For any WADA-tested athlete, turinabol is to be absolutely avoided.
How much realistic gains with turinabol alone?: In solo cycle (inadvisable due to suppression without androgen substitution): 40-60 mg/d × 8 weeks = +3 to +5 kg net lean mass retained at 3 months post-PCT. Excellent retention profile because little water retention. In combination testo 400 mg/week + tbol 40 mg/d × 8 weeks, the additive effect is more marked: +6 to +8 kg of which the majority retained. It is an excellent oral for users wanting to gain without bloat or brutal hormonal transformation.
Which AI to choose with dianabol?: The methylestradiol from dianabol aromatization is partially resistant to anastrozole. Exemestane (Aromasin) 12.5 mg EOD is more effective because it inhibits aromatase irreversibly (suicide enzyme), and its metabolite has slight androgenic activity. If gynecomastia already established, add nolvadex 20 mg/d. Measured estradiol monitoring (not only symptomatic) at W2 and W4 to titrate.
Is turinabol less hepatotoxic than dianabol?: Moderately. Both are 17α-alkylated, the main toxicity factor is this common modification. Niedfeldt 2018 classifies dianabol as more hepatotoxic mainly due to higher recreational doses and the combination of acute + chronic toxicity. Turinabol generates more modest ALT/AST elevations in bodybuilding practice, but the cholestasis risk remains present beyond 8 weeks. No 17α-alkylated oral is 'safe for the liver'.
Can you extend a turinabol cycle beyond 8 weeks?: Theoretically yes (turinabol is better tolerated long-term than dianabol), but practically not recommended. The cholestasis risk and lipid profile degradation become significant beyond 8 weeks for any 17α-alkylated drug. Prefer 6-8 weeks of turinabol then switch to an injectable (primobolan or masteron) to extend the cycle if necessary. No oral should be taken continuously on long cycle.
What PCT after dianabol or turinabol alone?: Start 3-4 days after last intake (short half-life). For dianabol alone: nolvadex 20-40 mg/d × 4-6 weeks, sufficient in most cases. For turinabol alone: nolvadex 20 mg/d × 4 weeks, sometimes sufficient at moderate dose. If T total panel < 300 ng/dL at W4 post-cycle, extend PCT to 6 weeks and add clomid 25 mg/d. No hCG needed in oral solo cycle. Complete panel (T total, LH, FSH, E2) at W6 post-PCT to confirm recovery.
Break between two oral cycles?: Minimum 8 weeks strict hepatic break without any 17α-alkylated drug. Hepatocyte regeneration is rapid (at 2-3 weeks transaminases return to normal in most), but complete resolution of cellular micro-lesions takes longer. Resuming any other oral before 8 weeks accumulates damage. Take advantage of the break to restart the HPG axis via clean PCT and do a complete panel. Resume an oral cycle only after biological panel back to normal.